Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034642132> ?p ?o ?g. }
- W2034642132 endingPage "142" @default.
- W2034642132 startingPage "133" @default.
- W2034642132 abstract "Melphalan-prednisone-thalidomide (MPT) and melphalan-prednisone-bortezomib (MPV) currently appear to be the treatments of choice for a large proportion of elderly multiple myeloma (MM) patients ineligible for autologous stem cell transplantation (ASCT). It seems certain that in the near future cyclophosphamide-thalidomide-dexamethasone, with an attenuated dose of dexamethasone (CTDa), and melphalan-prednisone-lenalidomide (MPR) will also be proved superior to MP, thus providing four therapeutic options in this patient group. These options could lead to more personalized treatment approaches, based on patient comorbidities, as the three novel agents have somewhat different toxicity profiles. MP would be appropriate for only a minority of patients with poor performance status and/or significant comorbidities. Questions regarding the relative efficacy of different melphalan-based regimens or melphalan-based regimens versus dexamethasone-based regimens with low-dose dexamethasone will require further trials. Additionally, the important issue of maintenance treatment needs to be investigated. These new and emerging therapies provide multiple effective treatment options for MM patients and greatly enhanced treatment strategies for clinicians, all offering promise that has been sorely lacking over the past four decades." @default.
- W2034642132 created "2016-06-24" @default.
- W2034642132 creator A5000193525 @default.
- W2034642132 creator A5020989412 @default.
- W2034642132 creator A5071589084 @default.
- W2034642132 creator A5089853890 @default.
- W2034642132 date "2009-04-01" @default.
- W2034642132 modified "2023-10-14" @default.
- W2034642132 title "Frontline Treatment in Elderly Patients With Multiple Myeloma" @default.
- W2034642132 cites W1506957333 @default.
- W2034642132 cites W1867927052 @default.
- W2034642132 cites W1895241868 @default.
- W2034642132 cites W1938721925 @default.
- W2034642132 cites W1984207121 @default.
- W2034642132 cites W1988092780 @default.
- W2034642132 cites W1989615427 @default.
- W2034642132 cites W2004136640 @default.
- W2034642132 cites W2010977839 @default.
- W2034642132 cites W2020778579 @default.
- W2034642132 cites W2033378587 @default.
- W2034642132 cites W2058115046 @default.
- W2034642132 cites W2060496777 @default.
- W2034642132 cites W2075290032 @default.
- W2034642132 cites W2082741854 @default.
- W2034642132 cites W2086529429 @default.
- W2034642132 cites W2093757149 @default.
- W2034642132 cites W2096207943 @default.
- W2034642132 cites W2097331346 @default.
- W2034642132 cites W2101576302 @default.
- W2034642132 cites W2108601475 @default.
- W2034642132 cites W2110466835 @default.
- W2034642132 cites W2117172636 @default.
- W2034642132 cites W2119584679 @default.
- W2034642132 cites W2120199307 @default.
- W2034642132 cites W2131915887 @default.
- W2034642132 cites W2132864753 @default.
- W2034642132 cites W2135514413 @default.
- W2034642132 cites W2138077682 @default.
- W2034642132 cites W2142149038 @default.
- W2034642132 cites W2143756652 @default.
- W2034642132 cites W2144531125 @default.
- W2034642132 cites W2146000276 @default.
- W2034642132 cites W2148188974 @default.
- W2034642132 cites W2152065071 @default.
- W2034642132 cites W2156748957 @default.
- W2034642132 cites W2160635879 @default.
- W2034642132 cites W2167310611 @default.
- W2034642132 cites W2168929741 @default.
- W2034642132 cites W2241053464 @default.
- W2034642132 cites W2264313156 @default.
- W2034642132 cites W2272366165 @default.
- W2034642132 cites W2275479821 @default.
- W2034642132 cites W2316160054 @default.
- W2034642132 cites W2498099382 @default.
- W2034642132 cites W2547188540 @default.
- W2034642132 cites W2550787877 @default.
- W2034642132 cites W2552699278 @default.
- W2034642132 cites W2556128583 @default.
- W2034642132 cites W2559045020 @default.
- W2034642132 cites W2561985459 @default.
- W2034642132 cites W2586028415 @default.
- W2034642132 cites W2589054503 @default.
- W2034642132 cites W2594070503 @default.
- W2034642132 cites W2598814067 @default.
- W2034642132 cites W2906534546 @default.
- W2034642132 cites W2980082982 @default.
- W2034642132 cites W2286997047 @default.
- W2034642132 cites W2333363976 @default.
- W2034642132 doi "https://doi.org/10.1053/j.seminhematol.2009.02.002" @default.
- W2034642132 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19389497" @default.
- W2034642132 hasPublicationYear "2009" @default.
- W2034642132 type Work @default.
- W2034642132 sameAs 2034642132 @default.
- W2034642132 citedByCount "4" @default.
- W2034642132 countsByYear W20346421322012 @default.
- W2034642132 countsByYear W20346421322014 @default.
- W2034642132 countsByYear W20346421322016 @default.
- W2034642132 crossrefType "journal-article" @default.
- W2034642132 hasAuthorship W2034642132A5000193525 @default.
- W2034642132 hasAuthorship W2034642132A5020989412 @default.
- W2034642132 hasAuthorship W2034642132A5071589084 @default.
- W2034642132 hasAuthorship W2034642132A5089853890 @default.
- W2034642132 hasConcept C126322002 @default.
- W2034642132 hasConcept C141071460 @default.
- W2034642132 hasConcept C143998085 @default.
- W2034642132 hasConcept C2776063141 @default.
- W2034642132 hasConcept C2776364478 @default.
- W2034642132 hasConcept C2776694085 @default.
- W2034642132 hasConcept C2776755627 @default.
- W2034642132 hasConcept C2777478702 @default.
- W2034642132 hasConcept C2778684742 @default.
- W2034642132 hasConcept C2778720950 @default.
- W2034642132 hasConcept C2779609412 @default.
- W2034642132 hasConcept C2780401358 @default.
- W2034642132 hasConcept C71924100 @default.
- W2034642132 hasConcept C98274493 @default.
- W2034642132 hasConceptScore W2034642132C126322002 @default.
- W2034642132 hasConceptScore W2034642132C141071460 @default.